BioMimetic Therapeutics, Inc. to Highlight Corporate Activities at the Stanford Group...

BioMimetic Therapeutics, Inc. to Highlight Corporate Activities at the Stanford Group Company Annual Healthcare Conference

FRANKLIN, Tenn.--(Business Wire)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that
Dr. Charles E. Hart, chief scientific officer, will provide an update
of corporate activities at the Stanford Group Company Annual
Healthcare Conference on Thursday, January 17 at 1:45 p.m. Eastern
Time. The conference is being held at the Four Seasons Hotel in
Washington D.C.

A live audio webcast of the presentation will be available at
http://webcast.streamlogics.com/audience/index.asp?eventid=65360 and
on the Company's website at www.biomimetics.com. The webcast will be
accessible for a period of at least 30 days.

About BioMimetic Therapeutics

BioMimetic Therapeutics, Inc. is developing and commercializing
bio-active recombinant protein-device combination products for the
healing of musculoskeletal injuries and disease, including orthopedic,
spine and sports injury applications. BioMimetic received marketing
approval from the FDA for its first product, GEM 21S(R), as a grafting
material for bone and periodontal regeneration following completion of
human clinical trials, which demonstrated the safety and efficacy of
its platform technology in this indication. Additionally, the Company
has clinical trials ongoing with its product candidates GEM OS1 and
GEM OS2 in multiple orthopedic bone healing indications including the
treatment of foot and ankle fusions and the stimulation of healing of
fractures of the arm. The Company's product and lead product
candidates all combine recombinant protein therapeutics with tissue
specific scaffolds to actively stimulate tissue healing and
regeneration.

For further information, visit www.biomimetics.com or contact
Kearstin Patterson, corporate communications, at 615-236-4419.

BioMimetic Therapeutics, Inc.
Kearstin Patterson, Corporate Communications
Office: 615-236-4419
Mobile: 615-517-6112
kpatterson@biomimetics.com

Copyright Business Wire 2008